| Identification | Back Directory | [Name]
STING-agonist-C11 | [CAS]
875863-22-2 | [Synonyms]
STING-agonist-C11
4-oxadiazol-2-yl]thio]-benzeneacetamide
N-[(methylamino)carbonyl]-α-[[5-(4-methylphenyl)-1
N-(methylcarbamoyl)-2-phenyl-2-((5-(p-tolyl)-1,3,4-oxadiazol-2-yl)thio)acetamide
N-[(METHYLAMINO)CARBONYL]-Α-[[5-(4-METHYLPHENYL)-1;3;4-OXADIAZOL-2-YL]THIO]-BENZENEACETAMIDE
Benzeneacetamide, N-[(methylamino)carbonyl]-α-[[5-(4-methylphenyl)-1,3,4-oxadiazol-2-yl]thio]- | [Molecular Formula]
C19H18N4O3S | [MDL Number]
MFCD07694415 | [MOL File]
875863-22-2.mol | [Molecular Weight]
382.44 |
| Hazard Information | Back Directory | [Description]
STING-agonist-C11 is an agonist of the STING pathway, inducing IFN secretion from human cells. STING-agonist-C11 activates the type I IFN response in a manner that requires the adaptor protein STING but does not require the alternative adaptors MAVS and TRIF, depending on signaling through STING to produce antiviral type I interferon. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
http://www.biorbyt.com |
|